A Basket Study of the Oral Selective Pan-FGFR Inhibitor Debio 1347 in Subjects with Solid Tumors Harboring a Fusion of FGFR1, FGFR2, or FGFR3 (FUZE)
A Basket Study of the Oral Selective Pan-FGFR Inhibitor Debio 1347 in Subjects with Solid Tumors Harboring a Fusion of FGFR1, FGFR2, or FGFR3 (FUZE)
Trial Category:
Other Solid Tumor
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
